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Cytochrome P450s (P450s) are a supergene family of en-
zymes responsible for the metabolism of a wide range of 
endogenous and foreign compounds. P450 isozymes possess 
overlapping substrate specificity. Systemic administration of 
dexamethasone, a widely used topical agent in dermatologic 
practice, to animals is known to result in the induction of 
multiple P450 isozymes in liver. In this study the effect of 
topical application of dexamethasone to mice on P450-
dependent monooxygenase activities, expression of P450 
isozymes, and P450 mRNA levels in skin was assessed. The 
treatment of mice with dexamethasone resulted in significant 
induction of7-ethoxyresorufin O-deethylase (2.3 times), 7-
pentoxyresorufin O-depentylase (19.2 times), para-nitro-
phenol hydroxylase (7.5 times), and erythromycin N-de-
methylase (2.2 times) activities; the monooxygenases 
catalyzed preferentially by P450 isozymes 1A1, 2B1, 2E1, 
and 3A, respectively. Immunoblot analysis of cutaneous mi-
crosomes, employing antibodies directed against purified 
T he cytochrome P450 (P450) isozymes belong to a multigene superfamily of enzymes responsible for the metabolism of a wide range of exogenous compounds such as drugs, carcinogens, and environmental chem-icals, as well as of endogenous substances such as fatty 
acids, prostaglandins, vitamin A, vitamin D, and steroids ([1-3] and 
references therein). Many of these P450s are products of different 
genes that encode proteins with distinct molecular weights, immu-
nologic reactivities, and substrate specifiicities [1,4-6] . Of36 P450 
gene families described so far, 12 families exist in all mammals 
examined [7]. and their inducibility, substrate turnover rates, and 
immunoreactivity with specific antibodies have been studied exten-
sively in extracutaneous tissues [1 ,7]. Much less, however, is known 
about P450s in cutaneous tissue [1 ,4]. 
Skin is a major organ that functions as an interface between for-
eign compounds such as solvents, drugs, environmental carcino-
gens, etc., and the body. Our laboratory has attempted to define the 
role of the P450 system in rodent and human skin with respect to 
the metabolism of chemical carcinogens and physiologically impor-
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P450s lAl/2, 2Bl/2, 2El, and 3A, showed that dexametha-
sone treatment results in an increased immunoreactivity 
(1.8 -13.9 times). In immunohistochemical staining of skin 
with antibody against P4502B1/2, topical application of 
dexamethasone resulted in an increased reactivity towards 
microsomal protein in the suprabasallayer of the epidermis 
and with the cells of the hair follicles. Whereas constitutive 
expression of mRNAs for CYP1A1 and CYP2E1 was evi-
dent in murine skin, any change in the levels of these mRNAs 
following treatment with dexamethasone was not apparent. 
The results of our study indicate that the application of dexa-
methasone to murine skin results in the induction of several 
families ofP450 isozymes, suggesting that murine skin con-
tains multiple inducible P450 isozymes capable of participat-
ing in the metabolism of a wide range of xenobiotics and 
endogenous compounds. Key words: cytochrome P450, dexa-
methasone, monooxygenase activities. ] Invest Dermatol1 02:970-
975, 1994 
tant endogenous compounds ([1,4,8 -11] and references therein). 
Most studies on cutaneous P450, however, have focused on 
P4501Al and its role in chemical carcinogenesis [12]. The bio-
chemical characteristics of P4501A1 isozyme and the inducibility 
following exposure to several polyaromatic hydrocarbons, p-
naphthoflavone (PNF) , glucocorticoids, etc. of monooxygenases, 
preferentially catalyzed by this isozyme, have been demonstrated in 
both human and rodent skin and in human hair follicles [13-17]. 
Studies employing polymerase chain reaction (peR) and Northern 
blot analysis have recently shown that treatment of neonatal rat skin 
and normal human epidermal keratinocytes in culture with PNF or 
benz(a)anthracene results in an increased expression ofP4501A1 at 
the mRNA level [18]. 
Glucocorticoids, which are widely used in clinical dermatology 
as topical antiinflammatory drugs, are known to induce several 
P450s, most notably P4503A, in liver via transcriptional activation 
and mRNA stabilization [19,20] . Earlier we suggested that multiple 
P450s exist in rodent and human skin ([1,4,10,16] and references 
therein). In this study, by assessing the effect of topical application 
of dexamethasone on mice during P450-dependent monooxygen-
ase activities, and the expression of P450 isozymes and mRNA 
levels, we provide evidence that multiple inducible P450s are 
present in murine skin. 
MATERIALS AND METHODS 
Chemicals 7-ethoxyresorufin and 7-pentoxyresorufin were purchased 
from Pierce Chemical Co., Rockford, IL. All reagents for sodium dodecyl-
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were obtained 
from Biorad Laboratories, Richmond, CA. Nitrocellulose membrane was 
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Table I. Induction of Cutaneous Monooxygenase Activities by Topical Application of Dexamethasone or Conventional Inducers ofP450s 
Monooxygenase Activities b 






20.6 ± 1.9 1.7 ± 0.2 0.04 ± 0.01 1.1 ± 0.1 
47.1 ± 3.2 (2.3)1 
407.9 ± 36.2 (19.8) 
ND 
32.6 ± 2.6 (19.2) 
NOt 
0.30 ± 0.03 (7.5) 
ND 
2.4 ± 0.2 (2.2) 
ND 
ND 
10.2 ± 0.9 (6.0) 
ND 
ND 




CSA ND ND 2.3 ± 0.2 (2.1) 
-: Fenule NMRI mice were treated topically with dexamethasone or other specific inducers as detailed in Materials atld Methods. Twenry-four hours after the last treatment, anim.ls 
were killed and skin microsomes prepared utilizing the treated area of the skin. 
b Monooxygenase activities were determined in microsomal suspensions as detailed in Materials atld Methods. Each assay was conducted in duplicate, and specific activiry data shown 
are mean ± SEM of four values; rwo skin samples were pooled for each determination. 
, pmol resorufin/min/mg microsomal protein. 
J nrnol 4-nitro catechol/min/mg microsomal protein. 
, nrool formaldehyde/min/mg microsomal protein. 
f Fold-induction compared to controls. 
I Not done. 
from Schleicher and Schuell, Keene, NH. The primary antibodies employed 
for Western blot analysis were either monoclonal prepared against rat liver 
microsomal P4501A1 (clone 1-7-1, a kind gift from Drs. H . V. Gelboin and 
S. S. Park, National Cancer Institute, Bethesda, MD) or rabbit polyclonal 
prepared against rat liver microsomal P4502Bl (002BI-P-RT), P4502El 
(002E 1-P-RT), and P4503A (003AO-P-RT), and were obtained from Oxy-
gene, Dallas, TX. Monoclonal antibody (MoAb) 1-7-1, in addition to 
p4501A1, also recognizes P4501A2 [21]. Secondary antibody and other 
reagents for immunoblotting were obtained from Kirkegaard & Perry, 
Gaithersburg, MD. Vectastain avidin-biofin peroxidase complex (ABC) kit 
for immunohistochemistry was purchased from Vector Laboratories, Inc., 
Burlington, CA. All the reagents employed for Northern blot analysis were 
from Promeaga Corp., Madison, WI. Other chemicals and reagents used 
were of highest purity commercially available. 
~als and Treatments Female NMRI mice (-22 g) were obtained 
frOUl Tieranstalt Winkelmann, Borchen, Germany, and were treated on 
their backs and sides either with 0.5 ml dexamethasone emulsion (0.1 % in 
water), 0.5 ml cyclosporin A (CSA; 0.1% in water), 0.5 ml crude coal tar 
(CeT), or 1 ml EtOH for ~~ c.onsecutive days. F~llowing these treatments, 
aniUlals were housed 111 1I1dlvldual cages to aVOId any oral absorptIOn of 
copically appli~d agents. T.wenty-four. hours after the last treatment, tl~e 
animals were blled by cervical dislocatIOn, and the treated areas of the sk1l1 
and liver were removed and immediately placed in ice-cold 0.15 M KCI. 
Preparation of Microsomal Fraction and Enzyme Assays Microso-
mal fractions from cutaneous tissues were prepared as decribed earlier [22]. 
In brief, skin samples, after removing the subcutaneous fat and muscle, were 
homogenized in 0.1 M phosphate buffer, pH 7.4, at 4·C using a Polytron 
tissue homogenizer (Brinkmann Instruments, Westbury, NY) as described 
earlier [22]. Skin homogenates thus obtained were centrifuged at 9000 X g 
for 20 min at 4· C, followed by centrifugation of the 9000 X g supernatant at 
100,000 X g for 60 min at 4"e. Liver microsomes were prepared as detailed 
elseW'here [23] . Skin and liver microsomal fractions were suspended in 0.1 M 
phosphate buffer, pH 7.4, containing 10 mM dithiothreitol, 10 mM ethy-
lenediaminetetraacetic acid (EDT A), and 20% glycerol. A part of the micro-
somal suspension was frozen at -170·C under liquid nitrogen for Western 
blot analysis, and the remaining was used on the day of preparation for the 
determination of enzyme activities. Protein was estimated in all the samples 
by the method of Bradford [24] using bovine serum albumin (BSA) as a 
standard. 
7-ethoxyresorufin O-deethylase (EROD) activity was determined ac-
cording to slight modification of the procedure of Pohl and Fouts [25] as 
described earlier [23]. 7-pentoxyresorufin O -depentylase activity (PROD) 
was determined according to the procedure of Lubet et al [26] with some 
modifications. In brief, identical steps were followed as in the case ofEROD, 
except that 7 -pentoxyresorufin was used as the substrate. Para-nitrophenol 
hydroxylase (PNPH) activity was determined by measuring the hydroxyla-
tion of para-nitro phenol to 4-nitrocatechol according to the method 
of Reinke and Moyer [27] as described by Koop [28]. Erythromycin 
N-demethylase (EMOM) activity was determined by measuring the forma-
tion of formaldehyde, generated by the demethylation of erythromycin, 
employing Nash reagent [29]. 
Western Blot Analysis The microsomal suspensions were denaturated 
by heating in boiling water for 10 min after the addition of2 X SDS-PAGE 
sample buffer (125 mM Tris-HCI, pH 6.8, containing 20% glycerol, 10% 
2-mercaptoethanol, 0.1% bromophenol blue, and 5% SDS), and samples 
were subjected to SDS-PAGE on 12.5% precasted polyacrylamide mini gels 
(Schleicher and Schuell), as described by Laemmli [30]. The resolved pro-
teins were transferred onto a nitrocellulose membrane as described by Tow-
bin et al [31]. After the transfer, the gels were stained to ensure equal protein 
loading and their subsequent uniform transfer onto the membrane. The 
nonspecific sites were blocked by incubating the membrane at room temper-
ature for 4 h in 5% nonfat dairy milk powder in PBS. The membrane was 
then incubated at room temperature overnight with desired antibody (50,ul 
antibody solution diluted with 10 ml PBS). The membranes were washed 
vigorously with PBS containing 0.05% Tween-20 (PBST), followed by 
PBS, and then incubated at room temperature for 6 h with alkaline phospha-
tase-conjugated secondary antibody to mouse or rabbit immunoglobulin 
(Ig)G (goat). Visualization ofP450 isozymes at membrane was achieved by 
color development using a mixture of 5-bromo-4-chloro-3-indolyl phos-
phate and nitroblue tetrazolium as the chromogenic substrates. The densities 
of immunoreactive bands were measured by a scanner (Epson GT 6000) with 
GEL Image software (Pharmacia, Freiburg, Germany). 
Immunohistochemistry Dorsal skin of untreated or dexamethasone-
treated mouse was removed, fixed in buffered 10% formalin, processed in 
paraffin wax, and 5-.um cryosections were cut. All sections were de paraffin-
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Figure 1. Induction ofP4501Al/2 isozyme in skin (A) and liver (B) by 
dexamethasone. The treatment protocol was the same as described in Materi-
als alld Methods. The microsomal proteins were resolved on SDS-PAGE, 
transferred to membrane, and immunoblotted with monoclonal antibody 
1-7-1, as described in Materials Qlld Methods. In both skin and liver micro-
somes, 20.ug protein was loaded per latle. Latles 1, 2, and 3, microsomes 
prepared from, respectively, ethanol-, CCT -, and dexamethasone-treated 
mice; ialle 4, untreated controls. The position of P4501Al/2 is based on 
molecular weight markers nor shown here. 
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Figure 2. Induction of P4S02Bl/2 isozyme in skin (A) and liver (B) by 
dexamethasone. The treatment protocol was the same as described in Materi-
als and Methods. The microsomal proteins were resolved on SDS-PAGE, 
transferred to membrane, and immunoblotted with polyclonal antibody 
directed against rat liver P4502B 1, as described in Materials atld Methods. In 
both skin and liver micro somes, 20 flg protein was loaded per lane. Lanes 1, 2, 
and 3, microsomes prepared from, respectively, ethanol- , CCT-, and dexa-
methasone-treated mice; lane 4, untreated controls. The position of 
P4S02Bl/2 is based on molecular weight markers. 
ized and rehydrated. The endogenous peroxidase activity was blocked by 
immersing the slides in 30% (w/v) hydrogen peroxide/methanol (1: 2, 
v Iv). The slides were then washed with phosphate-buffered saline (PBS) and 
incubated with Vectastain blocking solution for 30 min at 25°C in a humid-
ity chamber. The blocking solution was replaced with the primary rabbit 
polyclonal antibody aga'inst rat liver microsomal P4S02B1 isozyme (diluted 
1: 100 in PBS containing 0.1% BSA). The procedure employed for the 
visualization of antibody-reacting regions was the Vectastain avidin-biotin 
peroxidase method with diaminobenzidine as peroxidase substrate, essen-
tially as described in the vendor's protocol. 
RESULTS 
Effect of Topical Application of Dexamethasone on Cutane-
ous Monooxygenase Activities To assess the effect of topical 
application of dexamethasone on cutaneous P450, first we assessed 
the monooxygenase activities preferentially catalyzed by known 
P450s [1,4,6,7]. For comparison, we also assessed the effect of top i-
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Figure 3. Induction of P4S02El isozyme in skin (A) and liver (B) by 
dexamethasone. The treatment protocol was the same as described in Materi-
als aud Methods. The microsomal proteins were resolved on SDS-PAGE, 
transferred to membrane, and immunoblotted with polyclonal antibody 
directed against rat liver P4502E1, as described in Materials and Methods. In 
both skin and liver microsomes, 20 flg protein was loaded per latle. Lanes 1,2, 
atld 3, microsomes prepared from, respectively, ethanol-, CCT-, and dexa-
methasone-treated mice; lane 4, untreated controls. The position of 
P4S02El is based on molecular weight markers. 
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Figure 4. Induction ofP4S03A isozyme in skin (A) and liver (B) by dexa-
methasone. The treatment protocol was the same as described in Materials 
and Methods. The microsomal proteins were resolved on SDS-PAGE, trans-
ferred to membrane, and immunoblotted with polyclonal antibody directed 
against rat liver P4503A, as described in Materials and Methods. In both skin 
and liver microsomes, 20 flg protein was loaded per laue. La tIes 1, 2, and 3, 
microsomes prepared from, respectively, ethanol-, CCT-, and dexametha-
sone-treated mice; latle 4, untreated controls. The position of P4503A is 
based on molecular weight markers. 
cal application of known inducers of different monooxygenase ac-
tivities in skin. As shown by the data in Table I, 0 .1 % dexametha-
sone treatment for 2 d resulted in highly significant inductions, 
though of varying degrees, of EROD (2.3 times), PROD (19.2 
times), pNPH (7.5 times), and EMDM (2.2 times) activities, the 
monooxygenases catalyzed preferentially by P4501Al, P4502Bl/ 
2, P4502El, and P4503A, respectively. Topical application of 
CCT, phenobarbital , ethanol, and CSA, the known inducer ofp450 
isozymes lAl, 2Bl/2, 2El and 3A, respectively, also showed 19.8, 
6.0, 1.7, and 2.1 times induction in cutaneous EROD, PROD, 
pNPH, and EMDM activities (Table I). Similar effects of topical 
application of dexamethasone on the induction of different mon-
ooxygenase activities in the skin were also observed in SEN CAR 
mice (data not shown). 
Effect of Topical Application ofDexantethasone on Cutane-
ous P450 Isozymes As shown in Fig 1, compared to controls, 
topical application of dexamethasone resulted in significant increase 
(2.2 times induction over control in densitometric analysis of the 
bands) in the level ofP450lAl in skin (Fig lA), whereas no change 
in P4501A1 was evident in liver (Fig 1B) microsomes. A far more 
pronounced increase in the P4501A1 level was observed by CCT 
treatment in the case of both skin and liver (Fig lA,B), whereas 
ethanol treatment showed an increase in P4501A1 in skin but not 
liver (Fig 1A). 
Topical application of dexamethasone also resulted in a signifi-
cant increase (1.9 times induction over the control in densitometric 
analysis of the bands) in the level of P4502B1 in skin microsomes 
(Fig 2A). No change, however, in the level ofP4502B1 was evident 
by the topical application of either CCT or ethanol (Fig 2A). When 
liver microsomes, prepared from the mice topically applied with 
dexamethasone, CCT, or ethanol, were analyzed for P4502Bl/2 
isozyme, a very strong band for P4502B2 isozyme was evident only 
in the case of the dexamethasone-treated group (Fig 2B), showing a 
highly significant increase in this P450 isozyme following dexa-
methasone treatment of mice. No change in either P4502B1 or 
P4502B2 isozymes in liver, however, was observed by skin applica-
tion with CCT or ethanol (Fig 2B). 
As evident in Fig 3A, compared to control, topical application 
of dexamethasone also showed a highly significant increase in 
P4502E1 isozyme in skin microsomes. Unlike P4501A1 and 
P4502B1 isozymes, an approximately 14 times increase in cutane-
ous P4502E1 isozyme (based on densitometric analysis of the bands 
obtained in the cases of control and dexamethasone-treated skin 
microsomes) was observed following treatment of mice with dexa-
methasone (Fig 3A). Topical application of ethanol, a known in-
I 
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ducer of P4502El ([6,7,32] and references therein), and CCT, also 
showed a significant increase in the expression of P4502El iso-
zyme; however, the level of induction was far less than that ob-
erved with dexamethasone (Fig 3A). No detectable increase in the ~4502El isozyme was evident in liver microsomes obtained from 
either of the treated animals (Fig 3B). 
Western blot analysis for the detection of P4503A also showed 
similar patterns (Fig 4). In this case, based on densitometric analysis, 
dexamethasone treatment of mice showed a 1. 7 times increase in 
p4503A isozyme in skin microsomes (Fig 4A). Whereas compara-
ble results were obtained with CCT and ethanol in the case of skin 
rnicrosomes, no detectable change in P4503A isozyme was evident 
with liver microsomes prepared from either of the treated group of 
rnice, compared to controls (Fig 4A,B). It is important to mention 
here that whereas for EROD and EMDM activities the Western 
blot analysis data for P4501Al and P4503A isozymes were corrobo-
rative (Figs 1,2), there was a big difference in the catalytic activity 
data and P450 isozyme induction for PROD and pNPH activities 
(Table I) and P4502B1/2 and P4502E1 isozymes, respectively (Figs 
3,4). 
ImlDunohistochemical Localization of P4502Bl/2 in the 
Skin of Control and Dexamethasone-Treated Mice Because 
following dexamethasone treatment, the maximum increase (19.2 
times) occurred in PROD activity, and because PROD is preferen-
tially catalyzed by P4502B isozymes, for immunohistochemical 
studies we selected this P450 isozyme. As shown in Fig 5, in the case 
of control skin (Fig SA), antibody raised against P4502Bl/2 iso-
zyme showed reactivity in the suprabasal layer of the epidermis and 
with the cells of the hair follicle. Similar to catalytic activity and 
Western blot analysis data, topical application of dexametha-
sone resulted in a significant increase in the immunoreactivity to-
wards P4502Bl/2 isozyme in these compartments of the skin 
(Fig 5B). 
DISCUSSION 
Skin is the primary body site in direct contact with the environment, 
and, therefore, is a route through which many chemicals gain entry 
into the body. The introduction of chemicals into the body via skin 
occurs through both the passive contact of the skin with the envi-
ronment and by direct contact of chemicals on the body, viz drug 
therapy of skin diseases and cosmetics [33]. In this context, 
P450-dependent metabolism, in skin, of xenobiotics such as drugs, 
carcinogens, solvents, and other toxicants present in the environ-
ment is an important biotransformation pathway for these agents to 
be converted to their water-soluble metabolites, which could then 
be excreted from the body as such or following conjugation path-
ways ([1,4,12] and references therein). Ironically, the P450-
mediated process also generates chemically reactive metabolites of 
xenobiotics, which could bind covalently to cellular macromole-
cules, more precisely to DNA, leading to cell toxicity, mutagenic-
ity, and often cancer induction [1,4,12]. 
As reviewed recently by Mukhtar and Agarwal [4], P450 is also 
known to bioactivate different substances in the skin. Topical or 
systemic treatment of rodents with numerous xenobiotics has been 
shown to result in the induction of monooxygenase activities in skin 
[1,4]. Several studies have also shown that such an increase in en-
zyme activity is associated with the induction of specific P450 iso-
zymes in skin, which in turn is also specific to the type of xenobiotic 
exposure of skin [1,4]. Earlier we showed that topical application of 
3-methylcholanthrene to rat results in a significant increase in epi-
dermal P4501A1, with a concurrent increase in monooxygenase 
activities [10]. Similar results were also observed in both epidermis 
and liver following exposure of rat skin to CCT [34]. The induction 
j of P4501A 1 in human skin and in keratinocytes is also reported 
• following their exposure to different xenobiotics ([1,4] and refer-
ences therein) . Taken together, these studies suggested that, in skin, 
exposure to a xenobiotic results in the induction ofP4501A1. More 
recently, while assessing the metabolic capacity of reconstituted 
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epidermis from the outer root sheath cells of human hair follicle, a 
suggestion was made for the presence ofp4502B1 in reconstituted 
epidermis [35]. In the present study, we extend these observations 
by demonstrating that dexamethasone topically applied to mice 
results in the induction of P4501A1, P4502B1, P4502El, and 
P4503A in skin. 
It is known that systemic administration of dexamethasone in-
duces multiple P450 isozymes in liver; several studies have shown 
significant increases in P4502B and P4503A isozymes and their 
dependent monooxygenase activities, as well as mRNA, in liver 
following treatment with dexamethasone ([19,20] and references 
therein). Our data indicating that the application of dexamethasone 
to murine skin results in the induction of several subfamilies ofP450 
isozymes in skin also support previous findings, and suggest that 
murine skin contains multiple inducible P450 isozymes capable of 
participating in the metabolism of drugs, including glucocorticoids. 
With Northern blot analysis, we also assessed whether the increase 
in P450 isozymes in skin by topical application of dexamethasone 
also results in an increase in the amounts of mRNA for these forms 
ofP450s. Based on the known sequences for mouse cDNAs [36,37], 
the mRNA levels for CYPIA1 and CYP2E1 were determined in 
the skin of control and dexamethasone-treated NMRl mice. For 
comparison, we also used total RNA isolated from the skin of CCT-
or ethanol-treated mice. Whereas mRNA coding for CYP1Al and 
CYP2E1 were detectable in both control and dexamethasone-
treated skin, no increase in the levels of mRNA for these two P450 
genes was observed by the topical application of dexamethasone 
(data not shown). However, compared to controls, a 1.7 and 1.8 
times increase in mRNA for CYP1A1 and CYP2E1 by topical 
application of CCT and ethanol, respectively, was evident in these 
experiments (data not shown). With our results of enhanced en-
zyme activities and protein expression but unchanged mRNA ex-
pression after dexamethasone treatment, it seems possible that the 
effect of dexamethasone observed in the present study is due to 
protein stabilization. At least in liver, it has been shown that dexa-
methasone acts mainly via protein stabilization [19,20]. Our data 
showing a 14 times increase in P4502El isozyme compared to a 
sevenfold increase in pNPH activity by dexamethasone were also in 
accord with published findings showing P4502El induction in ex-
tracutaneous tissues by protein stabilization [32,38]. Besides, 
Northern blot analysis shows the constitutive expression of 
CYP1Al and CYP2El in murine skin. 
Although the levels ofp450s and their dependent monooxygen-
ase activities are low in skin compared to those in liver [1,4]' it is 
important to emphasize here that only a very small amount of topi-
cally applied drug is usually absorbed through the skin barrier stra-
tum corneum, which is not the case with the systemic administra-
tion of drugs and their metabolism in liver. Under these conditions, 
the corticosteroids, which are active in a very low concentration, 
may, therefore, be influenced even by the low levels ofP450 in skin. 
Moreover, the metabolism of different carriers and/or solvents in 
skin might have further influence on the pharmacologic activity of 
topically applied drugs. Our data, therefore, strongly suggest that 
the P450-dependent metabolism of corticosteroids and their inter-
action with P450 isozymes must be taken into consideration to 
explain their pharmacologic activities in the skin. In summary, the 
results of this study clearly demonstrate that multiple inducible 
P450 isozymes are constitutively present at least in murine skin, 
and that they may play an important role in the metabolism of topi-
cally applied drugs. These findings may help to develop new strate-
gies for the topical application of such drugs in dermatopharma-
cology. 
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i e 5. It. situ immunohistochemical localization of P4502Bl in control (A) and dexamethasone~trea~ed (B) NM.RI mouse s~in. Paraf.Iin-embe~ded ~e~ns were deparaffinized, incubated with 1 : 100 dilution of antibody to P4502Bl, and the color was vIsualized employmg Vectastam ABC kit, as descnbed 
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